Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Patriarca

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Transplantation and Cellular Therapy|April 10, 2021
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis LymphomasLuca Castagna, Anna Dodero, Francesca Patriarca, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 7, 2023
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccinationUmberto Pizzano, Gabriele Facchin, Chiara Marcon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2019
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective StudyFederica Sora, Carmen Di Grazia, Patrizia Chiusolo, et al.
Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2017
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple MyelomaLuisa Giaccone, Andrea Evangelista, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning RegimenAnna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Haematologica|January 19, 2007
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myelomaElena Zamagni, Cristina Nanni, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II TrialJacopo Peccatori, Sara Mastaglio, Fabio Giglio, et al.
Haematologica|April 10, 2002
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myelomaPatrizia Tosi, Elena Zamagni, Claudia Cellini, et al.
Frontiers in Oncology|November 12, 2020
Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)Francesca Patriarca, Alessandra Sperotto, Francesca Lorentino, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Transplantation and Cellular Therapy|April 10, 2021
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis LymphomasLuca Castagna, Anna Dodero, Francesca Patriarca, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 7, 2023
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccinationUmberto Pizzano, Gabriele Facchin, Chiara Marcon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2019
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective StudyFederica Sora, Carmen Di Grazia, Patrizia Chiusolo, et al.
Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2017
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple MyelomaLuisa Giaccone, Andrea Evangelista, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning RegimenAnna Dodero, Francesca Patriarca, Giuseppe Milone, et al.
Haematologica|January 19, 2007
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myelomaElena Zamagni, Cristina Nanni, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2019
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II TrialJacopo Peccatori, Sara Mastaglio, Fabio Giglio, et al.
Haematologica|April 10, 2002
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myelomaPatrizia Tosi, Elena Zamagni, Claudia Cellini, et al.
Frontiers in Oncology|November 12, 2020
Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)Francesca Patriarca, Alessandra Sperotto, Francesca Lorentino, et al.
Pageof 16